scholarly journals Galactosyl and sialyl clusters: synthesis and evaluation against T. cruzi parasite

2019 ◽  
Vol 91 (7) ◽  
pp. 1191-1207
Author(s):  
Andreza S. Figueredo ◽  
Peterson de Andrade ◽  
Thalita B. Riul ◽  
Marcelo F. Marchiori ◽  
Thais Canassa De Leo ◽  
...  

AbstractThe multivalent effect of carbohydrates (glycoclusters) has been explored to study important biological targets and processes involvingTrypanosoma cruzi(T. cruzi) infection. Likewise, CuAAC cycloaddition reactions (click chemistry) have been applied as useful strategy in the discovery of bioactive molecules. Hence, we describe the synthesis of 1,2,3-triazole-based tetravalent homoglycoclusters (1–3) and heteroglycoclusters (4and5) ofd-galactopyranose (C-1 and C-6 positions) and sialic acid (C-2 position) to assess their potential to inhibitT. cruzicell invasion and also its cell surfacetrans-sialidase (TcTS). The target compounds were synthesised in good yields (52–75 %)viaclick chemistry by coupling azidosugars galactopyranose and sialic acid with alkynylated pentaerythritol or tris(hydroxymethyl)-aminomethane (TRIS) scaffolds.T. cruzicell invasion inhibition assays showed expressive low parasite infection index values (5.3–6.8) for most compounds. However, most glycoclusters proved to be weak TcTS inhibitors at 1 mM (<17 %), except the tetravalent sialic acid3(99 % at 1 mM, IC50450 μM). Therefore, we assume thatT. cruzicell invasion blockage is not due to TcTS inhibition by itself, but rather by other mechanisms involved in this process. In addition, all glycoclusters were not cytotoxic and had significant trypanocidal activity upon parasite survival of amastigote forms.

2008 ◽  
Vol 5 (2) ◽  
pp. 91-93 ◽  
Author(s):  
Thomas Haselhorst ◽  
Fiona E Fleming ◽  
Jeffrey C Dyason ◽  
Regan D Hartnell ◽  
Xing Yu ◽  
...  

Polymer ◽  
2010 ◽  
Vol 51 (11) ◽  
pp. 2286-2295 ◽  
Author(s):  
Jiraphong Suksiriworapong ◽  
Kittisak Sripha ◽  
Varaporn Buraphacheep Junyaprasert

2021 ◽  
Author(s):  
Zhenke Yang ◽  
Yang Shi ◽  
Huiting Cui ◽  
Shuzhen Yang ◽  
Han Gao ◽  
...  

Mosquito midgut epithelium traversal is an essential component of transmission of malaria parasites. Phospholipid flippases are eukaryotic type IV ATPases (P4-ATPases), which in association with CDC50 cofactors, translocate phospholipids across lipid bilayers to maintain the membrane asymmetry. In this study, we investigated the function of a putative P4-ATPase, ATP7, from the rodent malaria parasite P. yoelii. Disruption of ATP7 results in block of parasite infection of mosquitoes. ATP7 is localized on the ookinete plasma membrane. While ATP7-depleted ookinetes are motile and capable of invading the midgut, they are quickly eliminated within the epithelial cells by a process that is independent from the mosquito complement-like immunity. ATP7 colocalizes and interacts with the flippase co-factor CDC50C. Importantly, depletion of CDC50C phenocopies ATP7 deficiency. ATP7-depleted ookinetes fail to translocate phosphatidylcholine (PC) across the plasma membrane, resulting in PC exposure at the ookinete surface. Lastly, ookinete microinjection into the mosquito hemocoel reverses the ATP7 deficiency phenotype. Our study identifies Plasmodium flippase as a novel mechanism of parasite survival in the midgut epithelium that is required for mosquito transmission.


2016 ◽  
Vol 21 (1) ◽  
pp. 118-132 ◽  
Author(s):  
Xueshun Wang ◽  
Boshi Huang ◽  
Xinyong Liu ◽  
Peng Zhan

2019 ◽  
Author(s):  
Yecheng Li ◽  
Chongze Zhao ◽  
Boyan Wei ◽  
Ling Wang

AbstractSummaryHybrid molecule-based drug design is the combination of two or more pharmacophoric moieties from identical or non-identical bioactive molecules, or known identical or non-identical bioactive molecules, into a single chemical entity. This strategy may be used to achieve better affinity and efficacy, or improved properties compared to the parent molecules, to interact with two or multiple targets, to reduce undesirable side effects, to decrease drug-drug interactions or to reduce emergence of drug resistance. The approach offers the prospect of better drugs for the treatment of many human diseases. Research activity in this area is increasing and has attracted many practitioners worldwide. To accelerate the design and discovery of new hybrid molecule-based drugs, it is essential to properly collect and annotate experimental data obtained from known hybrid molecules. To address this need, we have developed HybridMolDB, a manually curated database dedicated to hybrid molecules for chemical biology and drug discovery. It contains structures, manually annotated design protocols, pharmacological data, some physicochemical, ligand efficiency, drug-likeness and ADMET characteristics, and the biological targets of known hybrid molecules. HybridMolDB supports a range of query types, including searches by extensive text, protein sequence, chemical structure similarity and property ranges.AvailabilityHybridMolDB is freely available at http://www.idruglab.com/HybridMolDB/[email protected].


Sign in / Sign up

Export Citation Format

Share Document